EGFR and cancer: Therefore, several antibodies for EGFR have been developed and approved for cancer treatment, such as cetuximab (CTX), nimotuzumab, panitumumab, and necitumumab, and many nanoparticle formulations have been functionalized with these antibodies with the aim of better targeting.